• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.

作者信息

Moris Lisa, Van den Broeck Thomas, Wiegel Thomas

机构信息

Department of Urology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.

Department of Urology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.

出版信息

Eur Urol. 2020 Sep;78(3):e120-e121. doi: 10.1016/j.eururo.2020.07.005. Epub 2020 Jul 16.

DOI:10.1016/j.eururo.2020.07.005
PMID:32684306
Abstract
摘要

相似文献

1
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e120-e121. doi: 10.1016/j.eururo.2020.07.005. Epub 2020 Jul 16.
2
Reply to Fabiana Gregucci, Roberta Carbonara, and Alba Fiorentino's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e116-e117. doi: 10.1016/j.eururo.2020.05.036. Epub 2020 Jun 11.
3
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e114-e115. doi: 10.1016/j.eururo.2020.05.034. Epub 2020 Jun 10.
4
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e118-e119. doi: 10.1016/j.eururo.2020.06.057. Epub 2020 Jul 15.
5
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Nov;78(5):e192. doi: 10.1016/j.eururo.2020.07.031. Epub 2020 Aug 13.
6
Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.对弗朗切斯科·蒙托西、安德里亚·萨洛尼亚和阿尔贝托·布里甘蒂致编辑的信的回复，信的主题为：丽莎·莫里、马库斯·G·坎伯巴奇、托马斯·范登布罗克等人。高危局限性和局部进展性前列腺癌主要治疗方法的获益与风险：一项国际多学科系统评价。《欧洲泌尿外科杂志》2020年；77卷：614 - 27页。
Eur Urol. 2020 Nov;78(5):e193-e194. doi: 10.1016/j.eururo.2020.07.041. Epub 2020 Aug 21.
7
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Cosimo De Nunzio, Benjamin Brucker, Thomas Bschleipfer, et al. Beyond Antimuscarinics: A Review of Pharmacological and Interventional Options for Overactive Bladder Management in Men. Eur Urol 2021;79:492-504.回复船田聪、吉冈隆史和罗燕致编辑的信，信的内容是关于：科西莫·德农齐奥、本杰明·布鲁克、托马斯·施莱普费尔等人所著的《超越抗毒蕈碱药物：男性膀胱过度活动症管理的药理学和介入性选择综述》。《欧洲泌尿外科杂志》2021年；79卷：492 - 504页。
Eur Urol. 2021 May;79(5):e147-e148. doi: 10.1016/j.eururo.2021.02.033. Epub 2021 Mar 6.
8
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Marcus J. Drake, Amanda L. Lewis, Grace J. Young, et al. Diagnostic Assessment of Lower Urinary Tract Symptoms in Men Considering Prostate Surgery: A Noninferiority Randomised Controlled Trial of Urodynamics in 26 Hospitals. Eur Urol 2020;78:701-10.回复船田聪、吉冈隆史和罗燕致编辑的信，信的内容关于：马库斯·J·德雷克、阿曼达·L·刘易斯、格蕾丝·J·杨等。考虑前列腺手术的男性下尿路症状的诊断评估：一项在26家医院进行的尿动力学非劣效性随机对照试验。《欧洲泌尿外科杂志》2020年；78卷：701 - 710页
Eur Urol. 2021 Mar;79(3):e89-e90. doi: 10.1016/j.eururo.2020.12.004. Epub 2020 Dec 21.
9
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Antibiotic Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Eur Urol 2020;78:540-3.对船田聪、吉冈隆、罗燕致编辑的信的回复：关于阿什利·M·霍普金斯、加内桑·基切纳达塞、克里斯托斯·S·卡拉佩蒂斯等人的《阿特珠单抗治疗尿路上皮癌时联合使用抗生素与生存情况》。《欧洲泌尿外科杂志》2020年；78卷：540 - 543页。
Eur Urol. 2020 Dec;78(6):e227. doi: 10.1016/j.eururo.2020.09.021. Epub 2020 Sep 18.
10
Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.回复周雪亮和韩新伟致编辑的信，内容涉及：托马斯·范登布罗克、罗德里克·C·N·范登伯格、尼古拉斯·阿尔菲等人。前列腺癌根治性治疗后生化复发的预后价值：一项系统评价。《欧洲泌尿外科杂志》2019年；75卷：967 - 87页。
Eur Urol. 2019 Jul;76(1):e16. doi: 10.1016/j.eururo.2019.03.027. Epub 2019 Apr 6.